"We will continue to focus on a range of issues in relation to the PBS, of course, and important internal matters like governance, the Code of Conduct and listening to the membership - but our industry is also on the cusp of something quite extraordinary," says Vifor Pharma's James McDonnell. …
James McDonnell: Industry 'on the cusp of something quite extraordinary'
September 20, 2019 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
Who remembers the 'Vancouver' poster? We have a rerun
September 22, 2026 - - Latest News -
If there is a productivity gain in the process, then it should be passed on
September 22, 2026 - - Latest News -
Given the official use of AI, a cease and desist would not be unreasonable
September 22, 2026 - - Latest News -
Treasury has moved on from the PBS, but the policies built on its error have not
September 21, 2026 - - Latest News -
Nyrada banks $12 million as directors contribute in nearly half
September 21, 2026 - - Australian Biotech -
Telix announces takeover of ITM to create a global radiopharmaceutical powerhouse
September 21, 2026 - - Australian Biotech -
Only 2 per cent of Australians can name the signs of a heart condition behind one in four strokes
September 21, 2026 - - Latest News